Beneficial effect of the GLP-1 analogue liraglutide on blood pressure and cardiovascular biomarkers in subjects with Type 2 diabetes

被引：0
|
作者：
Vilsboell, T.
Zdravkovic, M.
Le-Thi, T.
Krarup, T.
Schmitz, O.
Courreges, J.
Verhoeven, R.
Buganova, I.
Madsbad, S.
机构：
[1] Gentofte Univ Hosp, Dept Internal Med, Copenhagen, Denmark
[2] Novo Nordisk AS, Clin Res Liraglutide, DK-2880 Bagsvaerd, Denmark
[3] Aarhus Univ, Dept Internal Med, Aarhus, Denmark
[4] Ctr Hosp Narbonne, Med Serv, Narbonne, France
[5] Poli Interne Geneeskunde, Gelre Ziekenhuizen, Apeldoorn, Netherlands
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] Liraglutide, a human GLP-1 analogue, reduces systolic blood pressure in subjects with type 2 diabetes
    Colagiuri, S.
    Frid, A.
    Zdravkovic, M.
    Le-Thi, T. D.
    Vaag, A.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S359 - S360
  • [2] Beneficial effects of Liraglutide, GLP-1 analogue, on cardiovascular risk factors in the type 2 diabetic
    Halimi, S.
    Lalanne, G.
    Ravaut, J. F.
    Reigneau, O.
    Dejager, S.
    DIABETES & METABOLISM, 2007, 33 : S18 - S18
  • [3] Liraglutide: A human GLP-1 analogue for the treatment of type 2 diabetes
    Sakauye, Stacie D.
    Shah, Sachin A.
    FORMULARY, 2009, 44 (05) : 136 - +
  • [4] Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes
    Matthews, D. R.
    Marre, M.
    Le-Thi, T. D.
    Zdravkovic, M.
    Simo, R.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S356 - S356
  • [5] Projecting the long-term clinical benefits of treatment with the GLP-1 analogue liraglutide in subjects with type 2 diabetes
    Valentine, William J.
    Hammer, Mette
    Palmer, Andrew J.
    Ray, Joshua A.
    DIABETES, 2007, 56 : A568 - A568
  • [6] In subjects with type 2 diabetes, liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure with negligible impact from weight loss
    Fonseca, V. A.
    Henry, R. R.
    Tabanera y Palacios, R.
    Brett, J.
    Plutzky, J.
    DIABETOLOGIA, 2010, 53
  • [7] The impact of GLP-1 analogue liraglutide on type 2 diabetes patients with and without insulin therapy
    Haq, Z.
    Reidy, Y.
    Dempsey, M.
    Reidy, C.
    Keogh, A. M.
    Hoashi, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S491 - S492
  • [8] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
    Vilsboll, Tina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
  • [9] Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline
    Schmitz, O.
    Russell-Jones, D.
    Shaw, J.
    Brandle, M.
    Matthews, D.
    Frid, A.
    Zdravkovic, M.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S354 - S355
  • [10] Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes
    Nauck, M. A.
    Hompesch, M.
    Filipczak, R.
    Le, T. D. T.
    Zdravkovic, M.
    Gumprecht, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (08) : 417 - 423
12345